Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.
Scope of the Report:
The worldwide market for Mental Illness Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Mental Illness Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antipsychotics
Antidepressants
Antianxiety (anxiolyitcs)
Anti-seizure medications
Stimulants
Cognitive disorders and dementia
Sleep disorder treatments
Substance abuse treatments
Market Segment by Applications, can be divided into
Hospital
Clinic
Drugstore
There are 15 Chapters to deeply display the global Mental Illness Drugs market.
Chapter 1, to describe Mental Illness Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Mental Illness Drugs, with sales, revenue, and price of Mental Illness Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Mental Illness Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Mental Illness Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Mental Illness Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Mental Illness Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antipsychotics
1.2.2 Antidepressants
1.2.3 Antianxiety (anxiolyitcs)
1.2.4 Anti-seizure medications
1.2.5 Stimulants
1.2.6 Cognitive disorders and dementia
1.2.7 Sleep disorder treatments
1.2.8 Substance abuse treatments
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drugstore
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson and Johnson
2.1.1 Business Overview
2.1.2 Mental Illness Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson and Johnson Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Mental Illness Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Mental Illness Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Mental Illness Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Mental Illness Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Mental Illness Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Mental Illness Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Mental Illness Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Mental Illness Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Mental Illness Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Mental Illness Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Mental Illness Drugs Market Analysis by Regions
4.1 Global Mental Illness Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Mental Illness Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Mental Illness Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Mental Illness Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Mental Illness Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Mental Illness Drugs Sales and Growth Rate (2013-2018)
4.5 South America Mental Illness Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Mental Illness Drugs Sales and Growth Rate (2013-2018)
5 North America Mental Illness Drugs by Countries
5.1 North America Mental Illness Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Mental Illness Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Mental Illness Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Mental Illness Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Mental Illness Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Mental Illness Drugs Sales and Growth Rate (2013-2018)
6 Europe Mental Illness Drugs by Countries
6.1 Europe Mental Illness Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Mental Illness Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Mental Illness Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Mental Illness Drugs Sales and Growth Rate (2013-2018)
6.3 UK Mental Illness Drugs Sales and Growth Rate (2013-2018)
6.4 France Mental Illness Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Mental Illness Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Mental Illness Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Mental Illness Drugs by Countries
7.1 Asia-Pacific Mental Illness Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Mental Illness Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Mental Illness Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Mental Illness Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Mental Illness Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Mental Illness Drugs Sales and Growth Rate (2013-2018)
7.5 India Mental Illness Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Mental Illness Drugs Sales and Growth Rate (2013-2018)
8 South America Mental Illness Drugs by Countries
8.1 South America Mental Illness Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Mental Illness Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Mental Illness Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Mental Illness Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Mental Illness Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Mental Illness Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Mental Illness Drugs by Countries
9.1 Middle East and Africa Mental Illness Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Mental Illness Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Mental Illness Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Mental Illness Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Mental Illness Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Mental Illness Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Mental Illness Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Mental Illness Drugs Sales and Growth Rate (2013-2018)
10 Global Mental Illness Drugs Market Segment by Type
10.1 Global Mental Illness Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Mental Illness Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Mental Illness Drugs Revenue and Market Share by Type (2013-2018)
10.2 Antipsychotics Sales Growth and Price
10.2.1 Global Antipsychotics Sales Growth (2013-2018)
10.2.2 Global Antipsychotics Price (2013-2018)
10.3 Antidepressants Sales Growth and Price
10.3.1 Global Antidepressants Sales Growth (2013-2018)
10.3.2 Global Antidepressants Price (2013-2018)
10.4 Antianxiety (anxiolyitcs) Sales Growth and Price
10.4.1 Global Antianxiety (anxiolyitcs) Sales Growth (2013-2018)
10.4.2 Global Antianxiety (anxiolyitcs) Price (2013-2018)
10.5 Anti-seizure medications Sales Growth and Price
10.5.1 Global Anti-seizure medications Sales Growth (2013-2018)
10.5.2 Global Anti-seizure medications Price (2013-2018)
10.6 Stimulants Sales Growth and Price
10.6.1 Global Stimulants Sales Growth (2013-2018)
10.6.2 Global Stimulants Price (2013-2018)
10.7 Cognitive disorders and dementia Sales Growth and Price
10.7.1 Global Cognitive disorders and dementia Sales Growth (2013-2018)
10.7.2 Global Cognitive disorders and dementia Price (2013-2018)
10.8 Sleep disorder treatments Sales Growth and Price
10.8.1 Global Sleep disorder treatments Sales Growth (2013-2018)
10.8.2 Global Sleep disorder treatments Price (2013-2018)
10.9 Substance abuse treatments Sales Growth and Price
10.9.1 Global Substance abuse treatments Sales Growth (2013-2018)
10.9.2 Global Substance abuse treatments Price (2013-2018)
11 Global Mental Illness Drugs Market Segment by Application
11.1 Global Mental Illness Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Drugstore Sales Growth (2013-2018)
12 Mental Illness Drugs Market Forecast (2018-2023)
12.1 Global Mental Illness Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Mental Illness Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Mental Illness Drugs Market Forecast (2018-2023)
12.2.2 Europe Mental Illness Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Mental Illness Drugs Market Forecast (2018-2023)
12.2.4 South America Mental Illness Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Mental Illness Drugs Market Forecast (2018-2023)
12.3 Mental Illness Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Mental Illness Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Mental Illness Drugs Market Share Forecast by Type (2018-2023)
12.4 Mental Illness Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Mental Illness Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Mental Illness Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Mental Illness Drugs Picture
Table Product Specifications of Mental Illness Drugs
Figure Global Sales Market Share of Mental Illness Drugs by Types in 2017